Bayer AG is locked in a desperate legal fight, appealing to the U.S. Supreme Court in a bid to block billions of dollars in damages over Roundup, a weedkiller linked to cancer. The German pharmaceutical giant inherited this massive litigation storm after acquiring Monsanto in 2018. With around 67,000 lawsuits still pending, Bayer has already spent $10 billion on settlements but faces even greater financial peril if the court doesn’t intervene. The company argues that federal law and the EPA’s safety assessment of glyphosate should shield it from state-level lawsuits demanding cancer warnings. A favorable ruling could drastically reduce future claims, while a defeat would cripple the company’s financial stability. As the legal battle rages on, Bayer’s fate may ultimately depend on the Supreme Court’s decision, marking a high-stakes moment in the company's history.
https://lk-99kor.blogspot.com/2025/04/bayers-desperate-plea-to-supreme-court.html
